Home
About
Overview
Sharing Data
ORCID
Help
History (25)
Spinal Canal
Dimethadione
Sequence requirement for peptide recognition by rat brain p21ras protein farnesyltransferase.
Striatal neurochemical changes in transgenic models of Huntington's disease.
The Alox5 gene is a novel therapeutic target in cancer stem cells of chronic myeloid leukemia.
See All 25 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The Alox5 gene is a novel therapeutic target in cancer stem cells of chronic myeloid leukemia.
Chen Y, Li D, Li S. The Alox5 gene is a novel therapeutic target in cancer stem cells of chronic myeloid leukemia. Cell Cycle. 2009 Nov 01; 8(21):3488-92.
View in:
PubMed
subject areas
5-Lipoxygenase-Activating Proteins
Animals
Benzamides
Carrier Proteins
Genes, abl
Humans
Hydroxyurea
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Lipoxygenase Inhibitors
Membrane Proteins
Mice
Mice, Knockout
Myeloproliferative Disorders
Neoplastic Stem Cells
Piperazines
Protein Kinase Inhibitors
Pyrimidines
authors with profiles
Shaoguang Li MD, PhD